Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Janus Living Inc. Class A-1 Common Stock (JAN) vs Morgan Stanley (MS) Price & Performance

Janus Living Inc. Class A-1 Common StockTrade
Morgan StanleyTrade

Price performance (Past 24H)

Key statistics

Janus Living Inc. Class A-1 Common Stock vs Morgan Stanley — how do they compare? Janus Living Inc. Class A-1 Common Stock trades at $28.51 (market cap $6.79B), while Morgan Stanley trades at $181.4 (market cap $285.07B). The key difference: Morgan Stanley is far larger — about 42× Janus Living Inc. Class A-1 Common Stock's market cap, and Morgan Stanley pays the higher dividend (2.53%). Which is the better fit depends on your goals — on Pluang, investors hold Janus Living Inc. Class A-1 Common Stock for 0 Days and Morgan Stanley for 90 Days on average.

JANMS
Market Cap
$6.79B$285.07B
Volume
1,802,8758,664,533
Sector
Real EstateFinancials
52-Week High
$31.76$228.42
52-Week Low
$22.88$154.37
Typical Hold Time
0 Days90 Days
Enterprise Value
$6.88B$286.44B
Dividend Yield
1.97%2.53%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Janus Living Inc. Class A-1 Common Stock

JAN trades at $28.85, up 0.42% today, with a neutral technical signal. The company, a senior housing REIT, reported a net loss of $61.10M in 2025, though revenue grew to $771.17M. Analyst sentiment is strongly positive with a 100% buy rating and a $32.91 consensus price target, representing a 14% upside. Recent developments include closing a $1.25 billion credit facility and declaring quarterly dividends.

The outlook is cautiously optimistic, driven by strong analyst support and strategic growth initiatives. Key opportunities include accretive acquisitions funded by recent capital raises. Risks include persistent negative profit margins, execution challenges in integrating new assets, and sensitivity to interest rate changes affecting REIT valuations.

Morgan Stanley

Morgan Stanley (MS) trades at $186.66, down 1.77% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $50.2B in 2022 to $66.0B in 2025, and a net income margin of 27.59%. Analyst consensus is bullish with a $225.50 price target, supported by growth in wealth management and AI financing.

The outlook remains positive given earnings momentum and strategic initiatives, but risks include volatile cash flows, high debt levels, and market sensitivity. Upside potential exists if the company capitalizes on capital markets recovery and AI demand, though investors should monitor leverage and macroeconomic headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JAN
100% Buy0% Sell
Avg holding period · 0 Days
MS
97% Buy3% Sell
Avg holding period · 90 Days

Top news

Latest headlines on both assets

About Janus Living Inc. Class A-1 Common Stock

Janus Living, Inc. is a real estate investment trust that owns and operates senior housing communities in US. Its portfolio comprises roughly 34 communities across 10 states, structured under RIDEA arrangements and externally managed by Healthpeak Investment Management.

Read more on JAN →

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS →